Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

2015 EBF 8th Open Meeting video interviews

3 Feb 2016
Clinical Drug development Interviews LBA MS (LC–MS/MS, HRMS, IMS) Regulated bioanalysis

Below is a selection of video interviews filmed at the 8th EBF Open Meeting, covering a wide range of interesting topics.

Interview with Tim Sangster and Kurt Sales (Charles River Laboratories) on the developing CRO industry and the challenges faced by sponsors

Interview with Christian Frisch (Bio-Rad AbD Serotec) on anti-idiotypic antibodies for PK assays and HuCAL® technology

Interview with Chris Beaver (inVentiv Health Clinical) on the recent trends in sponsor requests and how the CRO relationship with Pharma/biotech is evolving

Interview with Peter Ketelaar (PRA Health Sciences) on why EBF is a great event for the bioanalytical community and PRA’s new state-of-the-art laboratory in Assen, the Netherlands

Interview with Nico van de Merbel (PRA Health Sciences) on the regulatory challenges faced by bioanalytical laboratories and developments in the relationships between LBA and LC-MS scientists

Interview with David Lanham (Eurofins) on flow cytometry in bioanalysis

Top content

  • Novel liquid biopsy test enhances early cancer detection with high accuracy
  • Major M&A deals impacting bioanalysis in 2025
Previous article Next article

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone